Concepedia

Xinyao Du

XD

Statistics

Publications

7

Citations

4.1K

H-Index

7

Active since

2012

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

University of British Columbia

Encana (Canada)

Jiangnan University

Acuitas Therapeutics (Canada)

Xinyao Du is an author at Alnylam Pharmaceuticals (United States) specializing in nanocarriers for therapeutics, nanoparticle drug delivery, and drug delivery.

Publications per year

2012–2024

7

Publications

7

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

Akin Akinc, Martin A. Maier, Muthiah Manoharan et al. · Nature Nanotechnology · 2019 · 1.6K citations · Full text

, , +16

Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**

Muthusamy Jayaraman, Steven M. Ansell, Barbara L. Mui et al. · Angewandte Chemie International Edition · 2012 · 1.2K citations · Full text

, , +17

Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics

Martin A. Maier, Muthusamy Jayaraman, Shigeo Matsuda et al. · Molecular Therapy · 2013 · 619 citations · Full text

, , +17

Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles

Barbara L. Mui, Ying K. Tam, Muthusamy Jayaraman et al. · Molecular Therapy — Nucleic Acids · 2013 · 482 citations · Full text

, , +17

Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**

Muthusamy Jayaraman, Steven M. Ansell, Barbara L. Mui et al. · Angewandte Chemie · 2012 · 152 citations · Full text

, , +17

1–5 of 7